Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Jovanović M, Golušin Z.

Biomed Res Int. 2016;2016:5185303. doi: 10.1155/2016/5185303. Epub 2016 Apr 6. Review.

3.

Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.

Lerche CM, Wulf HC.

Dermatol Reports. 2010 Sep 14;2(2):e13. doi: 10.4081/dr.2010.e13. eCollection 2010 Aug 31. Review.

4.

Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.

Siegfried EC, Jaworski JC, Hebert AA.

Am J Clin Dermatol. 2013 Jun;14(3):163-78. doi: 10.1007/s40257-013-0020-1. Review.

5.

Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

Kim GK, Rosso JD.

J Clin Aesthet Dermatol. 2013 Feb;6(2):29-35.

6.

Update on the management of chronic eczema: new approaches and emerging treatment options.

Walling HW, Swick BL.

Clin Cosmet Investig Dermatol. 2010 Jul 28;3:99-117.

7.

Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Laws PM, Young HS.

Clin Cosmet Investig Dermatol. 2010 Apr 21;3:25-37.

8.

Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Elias PM, Wakefield JS.

Clin Rev Allergy Immunol. 2011 Dec;41(3):282-95. doi: 10.1007/s12016-010-8231-1. Review.

9.

Supplemental Content

Support Center